340B
Wasteful Spending on 340B Keeps Growing and Growing
One of the many programs whose problems seem to have gotten lost during the response to the COVID-19 pandemic is the 340B drug safety-net program.
Hospitals Serving Vulnerable Communities Chase Profits at the Expense of Patients
Patients across the country are receiving hospital care not knowing if they will get stuck with enormous and unexpected bills when they are released.
Taxpayers and Patients Win Second Round on 340B Drug Discount Rule
In January, Citizens Against Government Waste (CAGW) discussed a court case concerning a November 1, 2017 Centers for Medicare and Medicaid Services (CMS)
Drug Prices - The Council of Economic Advisers and Trump Administration Weigh In
Last Friday, on February 9, 2018, the White House Council of Economic Advisers released a 30-page report on, “Reforming Biopharmaceutical Pricing at Home and Abroad.
Taxpayers and Patients Win First Round on 340B Drug Discount Rule
Citizens Against Government Waste (CAGW) discussed in its November 7, 2017 WasteWatcher blog, a Centers for Medicare and Medicaid Services (CMS) final rule for Medicare Part B that will lower costs to taxp
New CMS Rule Will Help Reduce Drug Costs
On Wednesday, November 1, 2017, the Centers for Medicare and Medicaid Services (CMS) issued a new rule that will lower costs to taxpayers and Medicare beneficiaries for certain outpatient pharmaceuticals p
